Azitra, Inc. ("Azitra" or the "Company") (NYSE:AZTR), a clinical stage biopharmaceut

BRANFORD, Conn., Aug. 21, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE Americ

Anitra (AMEX:AZTR) reported quarterly losses of $(0.17) per share which missed the analyst consensus

BRANFORD, Conn., Aug. 12, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE Americ

ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the p

ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the p

ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the p

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m

Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar

SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth

Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and up

New Initiatives:ATR-COSF: Expansion into Cosmetic IngredientsOne of the most exciting initiatives en

BRANFORD, Conn., June 17, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE Americ

/PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focus

BRANFORD, Conn., June 4, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage b

BRANFORD, Conn., May 27, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage b

Anitra (AMEX:AZTR) reported quarterly losses of $(0.25) per share which missed the analyst consensus

BRANFORD, Conn., May 13, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE America

Patent offers broad protections for ATR-12, an engineered strain of S. epidermidis that expresses a

Preclinical data demonstrate ATR-01 delivers functional filaggrin, restoring skin barrier integrity

Azitra's spike is being fueled by a securities purchase agreement with healthcare-focused institutio

Azitra shares are trading higher Friday after announcing $10.5 million in private placement, with po

Dow falls 100+ points, S&P 500 and NASDAQ also down. Energy sector sees gains, consumer discreti

Planet Labs (PL) stock rose in pre-market trading after better-than-expected Q4 sales and strong FY2

Azitra shares jumped over 44% in after-hours trading following a $31.4 million financing deal to adv

Azitra shares jumped over 44% in after-hours trading following a $31.4 million financing deal to adv

Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.

Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.

Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovativ

BRANFORD, Conn., March 13, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage

BRANFORD, Conn., March 5, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) ("Azitra" or the "

https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_02042026_AZTR_Vandermosten.pdf

Anitra (AMEX:AZTR) reported quarterly losses of $(0.81) per share which missed the analyst consensus

BRANFORD, Conn., Feb. 27, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clin

MD Anderson Cancer Center expands ATR-04 clinical trial site footprint, offering potential to accele

BRANFORD, Conn., Feb. 19, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage

BRANFORD, Conn., Feb. 6, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage b

BRANFORD, Conn., Jan. 7, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clini